
Kiniksa Pharmaceuticals Hits New 52-Week High of $39.60
2025-10-27 17:07:57Kiniksa Pharmaceuticals International Plc achieved a new 52-week high of USD 39.60 on October 24, 2025, highlighting its strong performance in the pharmaceuticals sector. The company reported a 44.61% return over the past year and impressive financial metrics, indicating solid operational health and growth potential.
Read More
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 39.12
2025-10-02 22:45:43Kiniksa Pharmaceuticals International Plc achieved a new 52-week high of USD 39.12 on October 1, 2025, reflecting strong performance in the pharmaceuticals sector. The company reported a 54.56% return over the past year, significant net profit growth, and a solid balance sheet, showcasing its resilience in a competitive market.
Read More
Kiniksa Pharmaceuticals Hits New 52-Week High of $38.97
2025-10-01 16:49:04Kiniksa Pharmaceuticals International Plc achieved a new 52-week high of USD 38.97 on September 30, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company reported a 52.30% return over the past year and impressive net profit growth of 108.83%, highlighting its operational strength.
Read More





